is... watching & waiting
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CSE New Listing - Breathtec Biomedical Commences Trading on the Canadian Securities Exchange
Vancouver, British Columbia--(Newsfile Corp. - February 2, 2016) - Breathtec Biomedical (CSE: BTH) is the latest new listing on the Canadian Securities Exchange, and trades under the symbol "BTH". Breathtec, a medical diagnostics company, is focused on developing non-invasive, hand held breath testing and analysis tools for the early screening of diseases such as lung & breast cancers, alzheimers, parkinsons, tuberculosis, diabetes and liver disease. These diseases, and others, all produce distinctive signatures which can be distinguished in the breath.
Michael T. Costanzo, Ph.D., CEO, stated: "Researchers have been investigating blood-breath analysis for a number of years now, but its only recently that advances in detection equipment has reached the point where the possibility of miniaturized and highly specialized medical devices could be constructed for use in front line environments such as a general practitioners medical office."
The company recently closed a private placement consisting of 7.1 million units at a price of $0.25, raising gross proceeds of $1,775,000. Each unit consisted of one common share and one half a warrant, with each warrant exercisable at $0.40 until October 14, 2017.
http://www.stockhouse.com/news/press-releases/2016/02/02/cse-new-listing-breathtec-biomedical-commences-trading-on-the-canadian
Shoulda gone with your gut?
UVXY has options
Already back up for sale, GTC at .0038 - 24% in twenty minutes... get me outta here
About time, filled 240k at .003 for a flip
Running her into close to test this morning's gap
Gecko expecting -160 while FX calls for -200bcf... Thurs should be interesting
$2.029 holding the daily
Lol on a draw of 400... perhaps
This may go to $250 by March
What's the ticker to follow?
Bid in at $0.0034
Falling knife
Down is the only logical direction... the only thing that has me perplexed is Friday was as illogical as they come.
Another quarter could come off NG this month alone - no way the U doesn't split. Fear they'll do a 15 or 20 for one type thing given how short the last one stuck.
$15.8 to $16.7 in minutes.. seya NG
Winter's over for NG.. sell the news
The EIA's next storage report slated for release on Thursday, February 4 is expected to show a withdrawal of approximately 200 billion cubic feet for the week ending January 29.
Low volume move - would not be surprised if she gave it all back later in the week
Sounds like buy Fridays sell Wednesdays for Feb
Lmao my favorite:
We refuse to do things just for the sake of doing them
Like, we'd totally, like, never pay ihub $500 for a PR about nothing, believe us guys.. please!
Silence broken
Cannabix Technologies Licenses University of Florida Patent for Development of Marijuana Breathalyzer
Share Monday, February 1st 2016
Cannabix Hand-held THC Marijuana Breathalyzer is being developed to give law enforcement and employers the ability to test for recent consumption of the THC component of marijuana.
Vancouver, British Columbia (PRWEB) February 01, 2016
Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) is pleased to report it has exercised its option to license University of Florida US Patent 8,237,118 (“the Patent”) in the area of breath analysis of controlled substances. Cannabix entered into a research and patent option agreement with the University of Florida (“the University”) in July of 2015. Due to the positive results received on the FAIMS THC Breathalyzer development to date, Cannabix has moved to exercise its option to license the exclusive patent rights immediately. The Option exercise will give Cannabix exclusive worldwide rights in the area of breath analysis of controlled substances. In addition, Cannabix will be renewing its agreement with the University of Florida to continue development of its FAIMS-MS based marijuana breathalyzer.
Since the fall of 2015, Dr. Yost's group and Cannabix have been working diligently to optimize the high-field asymmetric waveform ion mobility spectrometry (FAIMS) cell for detection of trace amounts of THC through exhaled breath. The team has made consistent and impressive progress towards the development of a FAIMS- based hand held breathalyzer to accurately detect trace amounts of THC. The superior design developed by Dr. Yost’s team improves resolution, sensitivity and consistency using novel methods, with industry standard mass spectrometry being used for characterization.
Dr. Raj Attariwala, Cannabix’s Chief Scientific Officer, states, “FAIMS technology builds upon the current gold standard technique of Quadrupole Mass Spectrometry for measuring THC. This patent provides Cannabix with an engine to drive miniaturization of THC detection from exhaled breath, and the expertise provided by the Yost lab at the University of Florida is unparalleled in the analytical chemistry device development arena. This combination will lead Cannabix towards consistency and accuracy in real-time trace levels of THC detection in exhaled breath.”
Kal Malhi, President of Cannabix stated, “Cannabix is very pleased with the progress that we have made to achieve highly accurate detection of THC in breath using FAIMS technology. Due to positive results, we are immediately exercising our Option on US Patent 8,237,118, Partial Ovoidal FAIMS Electrode for breath analysis of controlled substances. Cannabix is a pioneer and a leader in the development of a FAIMS based THC Breathalyzer and we are cognizant of this lead position and the need to protect our know-how and developments. We are amassing a portfolio of intellectual property including patent protection for various devices and need to protect the details of our developments until the required patent protection is in place. Cannabix will provide updates on the development of its device as they occur and as patent protection requirements permit.
PITTCON 2016
Cannabix is pleased to report that Company officers and research delegates have been invited to present at the PITTCON 2016 conference on its technology development and know how in the area of breath testing for THC. PITTCON will be held from March 6-10, 2016 at the Georgia World Congress Center, Atlanta, Georgia.
PITTCON is the world’s largest annual premier conference and exposition on laboratory science. It is a scientific conference on leading discoveries and innovations in analytical chemistry and applied spectroscopy that serves life sciences, pharmaceutical discovery, environmental and bioterrorism industries. PITTCON attracts attendees from industry, academia and government from over 90 countries worldwide. Dr Rick Yost, Dr Bruce Goldberger and Dr Jared Boock will be presenting at the conference. Cannabix and Washington State University researcher Dr. Herbert Hill have been invited to present on THC breath testing technology at this prestigious event.
http://www.virtual-strategy.com/2016/02/01/cannabix-technologies-licenses-university-florida-patent-development-marijuana-breathalyz#axzz3yvD3qk5W
Wake up folks
UGAZ back to falling knife mode NG $2.18 crucial and about to fall.. back to $2.10
If $2.18 doesn't hold DGAZ $15 in a hurry
$13.4 .. What a weekend flip for anyone brave enough. Been sideways most of the morning, hope for a finish sub $12.6.
Dang $2.21 (-3.9%)
Scottrade has a PE of 6.8 a/o 9-30-15
For the rest of the winter, meteorologists forecast the weather will be about 17 percent warmer than normal in both February and March due to the effect of the El Nino weather pattern.
GL
Kool-aid in the food plaza, they should do well!
The talk about production going down is a magnifying glass for silver linings. Its the third week of decent draws, four weeks ago we were talking -58bcf, last week it was 'another snowy blast for DC this weekend'... now it's 55 and raining. The reaction Thursday was delayed bears were perhaps greedy, short $2.4's took profit.
I don't doubt it makes a run at $2.33-$2.36 next week but a double digit draw next month sends it to $2.06-$2.10, a two dollar day for DGAZ. Contango's the friend.
One of the other companies is on level two, 7 Vape
http://www.flatironcrossing.com/Directory/Details/400415
Somebody woke up US Equities
.0034 bid getting closer to Earth
Getting closer.. NG almost out of steam
Kiosk:
• RENT: ~$2,500-$5,000/month
• 100 Starter kits: ~$2,500
• (10) x 15ml Bottles of e-liquid in 20 flavors (0,6,12,18,24 NIC): ~$15,000.00
• phone/internet ~$200/month
• point of Sale ~$100/month (yearly subscription/1 seat)
• electric bill ~$150/month
• misc. ~$300/month
• marketing/promotion ~$100/month minimum
• + liability insurance ~$150/month
• + employee's pay (2 employees+25hrs/wk each=$1,800/month)
• + working mall hours (10am-10pm)
• TOTAL MONTHLY EXPENSE: ~$6,300-$8,800 minimum (NOT INCLUDING
PRODUCT)
http://vapementors.com/wp-content/uploads/2013/10/Special-Report6-Costs-to-open-FINAL.pdf
Na - cash ready to fade it
Awesome day here - holding over the weekend?
$2.38-$2.43 tops before $1.81